High Flow Oxygen Therapy Devices and Cannula Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2016-2021) and Forecast (2022-2028)

$ PRICE - $ 3,000.00$ 8,900.00

Global High Flow Oxygen Therapy Devices and Cannula Market: By Flow Rate (1-4 (Liter/Min), 5-40 (Liter/Min), 1-60 (Liter/Min)), By Application (For CPOD Patients, For Critical Care, For Neonatal and Pediatric Patients, Others), and Geography 

 

 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

High Flow Oxygen Therapy Devices And Cannula Market size was valued at USD x million in 2021 and is expected to reach USD x million by 2028, at a CAGR of x% during the forecast period 2022-2028. Due to mounting frequency of CPOD and other respiratory diseases. Moreover, growing elderly population and increasing cases of accidents are also surging the growth of the market. More than 65 million of population is affected by moderate-to-severe COPD. High-flow oxygen therapy (HFOT) is an innovative and non-invasive approach for treatment of patients suffering from acute or chronic respiratory failure. This report studies the market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities).

High Flow Oxygen Therapy Devices And Cannula Market

MARKET SUMMARY
-
x%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– x%
  • Largest Market– Asia-Pacific
  • Fastest Growing Market– North-America

High Flow Oxygen Therapy Devices Cannula Market

  • Global high flow oxygen therapy devices and cannula market report gives inclusive outlook on high flow oxygen therapy devices and cannula throughout the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
  • The report gives historical, current, and future market sizes (US$ Mn) on the basis of flow rate, application, and region.
  • Key stakeholders of the market report include suppliers, manufacturers, and marketers, policy makers engaged in global high flow oxygen therapy devices and cannula products.
Key Players
  • Fisher & Paykel
  • Vapotherm
  • Flexicare
  • ResMed
  • Medin
High Flow Oxygen Therapy Devices And Cannula Market

DRIVERS AND RESTRAINTS

The budding incidence of CPOD and other respiratory diseases are fueling the growth of global high flow oxygen therapy devices and cannula market. High flow therapy delivers respiratory gases at a high flow rate to support patients’ own natural breathing. It does this by generating positive pressure in the airways, aiding to keep them open. Moreover, it also improves the effective exchange of gases (by delivering oxygen and removing carbon dioxide) and makes breathing easier, while releasing patients’ respiratory muscles. Additionally, it also plays a role in handling dyspnea and hypoxemia. Furthermore, HFNC is used as a first line oxygen treatment to decrease the risk of requiring escalation to NIV or intubation.


North-America Got Significant Share

High Flow Oxygen Therapy Devices And Cannula Market

North America accounted for larger revenue share in global High Flow Oxygen Therapy Devices and Cannula market with significant CAGR owing to growing number of critical patient’s cases, increase in research and development for developing new treatment therapies, and better-quality healthcare facilities. Snowballing government support and funding in the research and development is also strengthening the growth of the market in North America. Europe accounted for a weighty share in market due to the growing number of accidents and critical patients survival cases. Asia Pacific is expected to grow suggestively due to their emerging economies, growing elderly population, and technological advancements.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Developments

  • For instance, in November 2017, Flexicare Limited a leading UK headquartered manufacturer of medical devices has acquired Medisize B.V.

Key

Findings of the Report

High Flow Oxygen Therapy Devices And Cannula Market Segmentation


Location

GEOGRAPHY


Report

Company Profile

  • Fisher & Paykel (New Zealand)
  • Vapotherm (New Hampshire)
  • Flexicare (UK)
  • ResMed (California)
  • Medin (New Jersey)

Description

High Flow Oxygen Therapy Devices And Cannula Market size was valued at USD x million in 2021 and is expected to reach USD x million by 2028, at a CAGR of x% during the forecast period 2022-2028. Due to mounting frequency of CPOD and other respiratory diseases. Moreover, growing elderly population and increasing cases of accidents are also surging the growth of the market. More than 65 million of population is affected by moderate-to-severe COPD. High-flow oxygen therapy (HFOT) is an innovative and non-invasive approach for treatment of patients suffering from acute or chronic respiratory failure. This report studies the market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities).

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX